Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis



Status:Terminated
Conditions:Neurology, Neurology, Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - Any
Updated:6/8/2018
Start Date:November 2013
End Date:September 30, 2015

Use our guide to learn which trials are right for you!

Study the cervical spinal cord and brain over time to assess changes and differences in
subjects with amyotrophic lateral sclerosis.

Investigators will study cervical spinal cord chemical concentrations and cervical spinal
cord and brain microstructure in amyotrophic lateral sclerosis(ALS) patients who have had a
stem cell transplant compared to ALS patients who have not had a stem cell transplant.
Investigators intend to determine cervical spinal cord chemical concentrations and cervical
spinal cord and brain microstructure in amyotrophic lateral sclerosis(ALS) patients who have
had a stem cell transplant and compare these to corresponding measures in amyotrophic lateral
sclerosis(ALS) patients who have not had a stem cell transplant.

Inclusion Criteria:

1. 18 years of age or older

2. Subjects with amyotrophic lateral sclerosis -

Exclusion Criteria:

1. Do not have opportunistic central nervous system infection

2. Do not have a history of head injury

3. Do not have cerebrovascular disease

4. Do not have a contraindication for MRI(e.g. cardiac pacemaker, ferromagnetic or
metallic implants).

5. Must not be pregnant -
We found this trial at
1
site
Ann Arbor, Michigan 48109
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials